OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$20.50
-0.64 (-3.03%)
▼
5d:
-6.78%
30d:
+10.39%
90d:
+36.21%
HOLD
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Accumulation
None View Scanner →
Strength: 8.5/10
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called OSCR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OSCR trades at premium valuation expecting 7.2% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: OSCR trades at premium valuation expecting 7.2% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$32.41
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$20.13
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $20.50, which is considered fair relative to its 30-day fair value range of $19.08 to $23.55. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.7) compared to its historical average (11.9). At these levels, the market is pricing in 7.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSCR is in a uptrend. The price is currently testing key support at $20.09. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OSCR is in a uptrend. The price is currently testing key support at $20.09. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$19.08 -
$23.55
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
62.9%
Protect Your Profits
Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- NEUTRAL: Near Wall St target ($21.20)
- NEUTRAL: PE elevated vs history but 7.2% growth expectation is conservative given 126% recent growth
- CAUTION: Recommendation downgraded due to -6.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$19.08 -
$23.55
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$20.09
Resistance Level
$24.70
Current Trend
Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.66
Wall Street Target
$21.20
(+3.4%)
Revenue Growth (YoY)
52.6%
Earnings Growth (YoY)
125.6%
Profit Margin
-0.3%
Valuation Premium vs History
+7.2% premium
PE vs Historical
14.7 vs 11.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.2%
(market-implied from PE analysis)
1-Year Target
$21.98
(+7%)
2-Year Target
$23.56
(+15%)
3-Year Target
$25.25
(+23%)
3-Yr Target (if PE normalizes)
(PE: 15→12)
PE COMPRESSION
$20.50
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 39.0%)
$82.39
(+302%)
Base:
(SPY PE: 14.7, Growth: 39.0%)
$55.11
(+169%)
Bear:
(PE: 11.9, Growth: 39.0%)
$44.75
(+118%)
Share & Embed Analysis
Last updated: June 03, 2026 7:22 PM ET
Data refreshes hourly during market hours. Next update: 8:22 PM
Data refreshes hourly during market hours. Next update: 8:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark T Bertolini
BUY
1000000 shares
2026-04-06
Mario Schlosser
SELL
23038 shares
2026-01-08
Mario Schlosser
SELL
76962 shares
2026-01-06
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$102 | 58 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$395 | 56 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$342 | 54 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$401 | 52 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$263 | 57 HOLD |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
